Please login to the form below

Inyta

This page shows the latest Inyta news and features for those working in and with pharma, biotech and healthcare.

Institute's draft guidance doesn't recommend drug for advanced kidney cancer

CHMP roundup – new drug recommendations in Europe

There were also CHMP decisions this month on Pradaxa's labelling and recommendations for Pfizer's Inyta and Vertex Pharma's cystic fibrosis treatment Kalydeco.
Pfizer's Inlyta backed by EMA for kidney cancer in EU

Agency recommends drug as second-line therapy in adults with advanced renal cell carcinoma

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Director development role to Business Director, H...: Excellent package

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Add my company

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...